公司资料
NeuroSense Therapeutics 股价、新闻与催化剂
- 股票代码:
- NRSN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Israel and listed in the U
股票表现
0.38 USD (+7.39%)
收盘价
最后更新: 2026年8月21日
28.9M USD
市值
股价为何变动
As of Aug 21, 2026, NRSN closed up 7.39% at $0.3763. No new same-company headline was identified in the current news window.
公司概览
业务概览
NeuroSense Therapeutics is a biotechnology company focused on neurodegenerative diseases such as ALS and related conditions. Its story centers on trying to develop therapies for some of the hardest diseases in CNS medicine.
所在地与行业分类
NeuroSense is headquartered in Israel and listed in the U.S. market. It sits in neuroscience biotechnology.
商业模式特征
The company depends on clinical proof, translational confidence, and capital efficiency while advancing a narrow neurologic pipeline. Investors usually watch early data and strategic developments.
生物医药行业定位
NeuroSense occupies a high-catalyst neurodegeneration niche within biotech. The stock is highly dependent on whether its programs can show meaningful neurologic benefit.
未来催化剂
- NeuroSense’s catalysts are primeC and its neurodegeneration programs, plus any update that shows the platform can still keep moving. The company still needs human proof.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。